Invisible Nation is a worldwide network of patient organizations committed to driving a decline in cardiovascular (CV) death by effecting systemic change in atherosclerotic cardiovascular disease (ASCVD) care
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular disease
The study showed a significant 29% reduction in the risk for heart attack, stroke and death from any cause in the Wegovy users
Merck will share two oral presentations on ASCVD treatment patterns and patient burden
GE HealthCare’s Revolution Vibe CT enables more facilities to elevate patient care by offering advanced cardiac imaging technology
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Quinidine Sulphate helps manage rare irregular heartbeat conditions
35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases
These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more
Subscribe To Our Newsletter & Stay Updated
